Quoin Pharmaceuticals Ltd DRC (QNRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $17.78M
Last updated: Nov 17, 2026 at 11:06 AM ET
Quoin Pharmaceuticals Ltd DRC (QNRX) Competitors
The companies most similar to Quoin Pharmaceuticals Ltd DRC are Quantum BioPharma (QNTM), Quince Therapeutics (QNCX) and Context Therapeutics (CNTX). By market cap, Quoin Pharmaceuticals Ltd DRC ranks 5th of the 13 companies on this page; Rein Therapeutics (RNTX) is the largest at $47.63M.
Peer Comparison
QNRX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd DRC (QNRX) | $17.78M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Quantum BioPharma Ltd. (QNTM) | $10.35M | N/A | N/A | 0.0% | -150.1% | 0.0% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pluri Inc. (PLUR) | $15.09M | N/A | 8.7x | 0.0% | -650.8% | -15.8% | 0.00% |
| Neuphoria Therapeutics Inc (NEUP) | $13.80M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cocrystal Pharma Inc (COCP) | $18.88M | N/A | 39.2x | 0.0% | N/A | 26.9% | 0.00% |
| Citius Pharmaceuticals Inc (CTXR) | $14.69M | N/A | 1.9x | 0.0% | -84.3% | 0.0% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| Vyome Holdings, Inc. (HIND) | $11.09M | N/A | N/A | 0.0% | N/A | 67.5% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Passage Bio Inc (PASG) | $13.68M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $15.41M | N/A | 5.4x | 0.0% | -400.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Quoin Pharmaceuticals Ltd DRC, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Quantum BioPharma Ltd. (QNTM) | Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on advancing transformative therapies for oncology and autoimmune diseases. | QNTM competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. | |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| Pluri Inc. (PLUR) | Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy... | PLUR competitors |
| Neuphoria Therapeutics Inc (NEUP) | Neuphoria Therapeutics Inc (Ticker: NEUP) is a groundbreaking biotechnology firm focused on revolutionizing mental health disorders treatment via psychedelic... | NEUP competitors |
| Cocrystal Pharma Inc (COCP) | Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic... | COCP competitors |
| Citius Pharmaceuticals Inc (CTXR) | Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. | CTXR competitors |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| Vyome Holdings, Inc. (HIND) | Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States... | HIND competitors |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Passage Bio Inc (PASG) | Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. | PASG competitors |
Frequently Asked Questions About QNRX
Who are Quoin Pharmaceuticals Ltd DRC's main competitors?
The companies most similar to Quoin Pharmaceuticals Ltd DRC include Quantum BioPharma (QNTM), Quince Therapeutics (QNCX), Context Therapeutics (CNTX), Pluri (PLUR) and Neuphoria Therapeutics (NEUP), listed from the closest match.
Who is Quoin Pharmaceuticals Ltd DRC's biggest competitor?
Rein Therapeutics (RNTX) is the largest of the similar companies at $47.63M; Quantum BioPharma (QNTM) is the closest match by business profile, size, sector and industry.
How does QNRX stock compare with its competitors?
QNRX's net margin is 0.0% against a peer median of 0.0%.
Which of Quoin Pharmaceuticals Ltd DRC's competitors pays a higher dividend?
Quoin Pharmaceuticals Ltd DRC pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Quoin Pharmaceuticals Ltd DRC bigger than its competitors?
No. Quoin Pharmaceuticals Ltd DRC is 5th by market cap among the 13 companies on this page; the largest is Rein Therapeutics (RNTX) at $47.63M.
QNRX pages: Overview, Earnings, Forecast, Financials, Competitors